Podimetrics, a Somerville, Mass.-based creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, raised $45m in Series C funding.
The round was led by D1 Capital Partners, with participation from two new investors, the Medtech Convergence Fund and an undisclosed strategic investor, as well as existing investors Polaris Partners and Scientific Health Development.
The company intends to use the funds to hire to build out their product development and research teams and expand the breadth of services delivered by their nurse support team.
Founded in 2011 by Jon Bloom, MD, CEO, Podimetrics is the creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex diabetic patients. Through partnerships with regional and national health plans and at-risk providers, such as the Veterans Health Administration, Podimetrics has helped prevent amputations associated with complex diabetes.
FinSMEs
24/03/2023